Primary Site >> Liver Cancer
Gene >> FLT3
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. PMID: 16890795 Ref: Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. PMID: 17178882 |
Ref: Protein kinase inhibitors in the treatment of renal cell carcinoma: sorafenib. PMID: 17591826 Ref: Effective palliation of advanced cholangiocarcinoma with sorafenib: a two-patient case report. PMID: 19089671 |
Ref: Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies. PMID: 19894779 |
Ref: Antiangiogenic drugs in oncology: a focus on drug safety and the elderly - a mini-review. PMID: 19940466 Ref: Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China. PMID: 20698202 |
Ref: Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression. PMID: 21545220 Ref: Sunitinib induced pyoderma gangrenosum-like ulcerations. PMID: 22027642 |
Ref: Transforming growth factor-beta-stimulated clone-22 is a negative-feedback regulator of Ras / Raf signaling: Implications for tumorigenesis. PMID: 21943131 Ref: Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development. PMID: 22214462 Ref: Rational drug design for identifying novel multi-target inhibitors for hepatocellular carcinoma. PMID: 22583422 Ref: Discovery of potent, orally active compounds of tyrosine kinase and serine/threonine-protein kinase inhibitor with anti-tumor activity in preclinical assays. PMID: 23983378 |
Ref: Sorafenib Induced Hand Foot Skin Rash in FLT3 ITD Mutated Acute Myeloid Leukemia-A Case Report and Review of Literature. PMID: 24678393 |
Ref: Profile of nintedanib in the treatment of solid tumors: the evidence to date. PMID: 26677336 |
Ref: Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia. PMID: 26907662 Ref: Role of FLT3 in the proliferation and aggressiveness of hepatocellular carcinoma. PMID: 27511526 |
Ref: Cabozantinib in the treatment of hepatocellular carcinoma. PMID: 28703624 |
Ref: Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis. PMID: 29785143 |